HTB

Prevention and transmission

HIV diagnoses in UK drop for third year: among all ages, risk groups, and ethnicities and across most UK regions

English court finds in favour of access to generic TDF/FTC

High rates of anal HPV infection in gay men using PrEP in IPERGAY: the role of vaccination

Janssen HIV vaccine: update from APPROACH and largescale efficacy study

Resolving a diagnosis for people with persistently indeterminate HIV test results

Zero HIV transmissions in PARTNER study after gay couples had sex 77,000 times without condoms – an undetectable viral load stops HIV

Using PrEP with feminising hormone therapy supports daily PrEP dosing for transwomen

Daily and on-demand PrEP both prevent HIV in Prévenir study: high adherence by gay Parisians

Why U=U does not apply to breastfeeding

New FDA guidance for developing PrEP drugs

UK PrEP IMPACT trial announces 3000 new places for gay men but low uptake by women, African and transgender people

Broad PrEP access in Australia reduces HIV infections even with reduced condom use by people not on PrEP

Webcasts on PrEP and women

Low PEP and PrEP awareness among trans people in London and their partners

Low awareness of PrEP in BME communities in Leeds but high interest in use

Zero or negligible risks of HIV, HBV or HCV transmission by biting or spitting

Almost 1 in 8 people with symptoms turned away from sexual health clinics in SE London: 40% are under 25 and 6% under 18 years old

Rapid PrEP uptake in Scotland exceeds expectations

PrEP engagement workshops

Update on PrEP IMPACT study (March 2018)

PrEP at CROI 2018 (part 1): Access in Australia and the US

PrEP at CROI 2018 (part 2): Animal studies for future drugs

London clinic to prescribe generic PrEP privately at £55 for 30 tablets

HIV in the UK 2017: a shift to eliminate AIDS

Update on PrEP IMPACT study – January 2018

PrEP use can reduce HIV stigma in gay communities

European HIV/AIDS surveillance report published (2017)

London signed up as a fast-track HIV city by Mayor Sadiq Khan

Screening HIV positive pregnant women for TB in South Africa increased detection by 10-fold

Updates from the PrEP IMPACT study – November 2017

New guides to PrEP

Featured The evidence for U=U (Undetectable = Untransmittable): why negligible risk is zero risk

New IPERGAY analysis shows on-demand PrEP dosing works with less frequent sex

On-demand dosing for PrEP is highly effective in French expanded access programme

Psychological impact of PrEP: beyond efficacy and cost-effectiveness

Early ART and testing HIV negative with rapid HIV tests

UK PrEP guidelines: online for comment

NHS access to PrEP in the UK: country update

Generic PrEP in France and Scotland challenges access across the UK

PrEP use in adolescent gay and bisexual men: US study shows need for easier access and easier PrEP

MK-8591: further compelling early results for both treatment and prevention

Gay men with undetectable viral load do not transmit HIV: Opposites Attract study supports U=U

Controversial PrEP study from NHS England due to start in September

HIV superinfection is associated with specific HLA types

New study of combined HIV prevention and contraception ring

Online video: PrEP 17 – The coming of age of PrEP

Drop in HIV incidence in gay men: frequent testing, early ART and PrEP

Potential for phylogenetic analysis to show direction of HIV transmission

Initiatives for earlier HIV diagnosis: opt-out ER and home testing

No new HIV cases in 398 people using PrEP at Dean Street clinic

PrEP in pregnancy does not increase poor birth outcomes

PrEP approved in Scotland but not in Wales

Acute infection with wild-type HIV on PrEP with good drug levels

Brighton heads towards zero HIV: first UK city with UN Fast Track status

Four London clinics report dramatic drops in HIV incidence in gay men: PrEP, early testing and early ART likely to be key

NHS England fudges PrEP access and delays on-demand access to PrEP by years; blocks doctors from prescribing PrEP now

Update on PrEP in Scotland

New York reports fewer HIV diagnoses in 2015: target to reduce new infections by 75% by 2020

UK Guide to PrEP (2nd Edition)

Generic PrEP bought online for UK use is validated by drug testing service

2nd HIV Research for Prevention Conference (HIVR4P) 2016, 17-20 October 2016, Chicago

A burgeoning PrEP pipeline: dozens of new drugs, formulations and delivery options

Second case of drug resistant HIV infection in person adherent on PrEP

TDF/FTC can be used as PrEP by breastfeeding mothers without risk to the baby

Potential for EFdA as PrEP to prevent HIV transmission in women and their infants

Post navigation